Innovations in Immunology: Drug resistance is a constant threat to progress in HIV, TB and malaria vaccines

September 3, 2019

Despite global efforts at prevention and improving control, the public health impact of these diseases is still huge. Medicines are the mainstay of control efforts, but drug resistance is a constant threat. Effective vaccines are urgently required and would add substantially to the ongoing efforts to curb these diseases.

The first vaccine against malaria to receive a positive opinion from the European Medicines Agency will soon be tested in implementation trials in three African countries: Kenya, Malawi and Ghana.

Read the full article here

More News

ASI announces their new ASI Global Outreach Award

August 9, 2023

FIMSA Travel Awards for IUIS 2023 Congress

June 20, 2023ASI announces their new ASI Global Outreach Award, Federation of Immunological Societies of Asia-Oceania (FIMSA)

2023 World Laureates Association Prize (WLA Prize)

May 22, 2023

Michelson Prizes

April 12, 2023

2023 International Day of Immunology

February 23, 2023

IUIS celebrates the International Day of Women and Girls in Science on February 11

February 9, 2023

IUIS-FAIS-SANTHE-ISZ-Immuno-Zambia 2022

December 21, 2022ASI announces their new ASI Global Outreach Award, Education Committee (EDU)

Funding Opportunity from IUIS and FOCIS for Young Immunologists from the Developing World

December 1, 2022ASI announces their new ASI Global Outreach Award, Gender Equality Committee (GEC)

IUIS-GEC National Gender Equality Campaign – Competition4ideas

November 29, 2022ASI announces their new ASI Global Outreach Award, Gender Equality Committee (GEC)